Autori: Andric Zoran G
| Naslov | Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial (Article) |
| Autori | Verschraegen Claire Andric Zoran G Moiseenko Fedor Makharadze Tamta Shevnya Sergii Oleksiienko Alona Ruiz Eduardo Yanez Kim SungHyun Ahn KeumYoung Park TaeHong Park Sijin Ju Hana Ohe Yuichiro |
| Info | BIODRUGS, (2022), vol. 36 br. 6, str. 749-760 |
| Projekat | Celltrion, Inc. (Incheon, Republic of Korea) |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2 (Article) |
| Autori | Goel Shom Tan Antoinette R Rugo Hope S Aftimos Philippe Andric Zoran G Beelen Andrew Paul Zhang Jingshan Yi John S Malik Rajesh K O'Shaughnessy Joyce |
| Info | FUTURE ONCOLOGY, (2022), vol. 18 br. 33, str. 3701-3711 |
| Projekat | G1 Therapeutics; Eli Lilly; Merck; Pfizer; AstraZeneca; Ayala; Boehringer Ingelheim; Daiichi; Gilead; Lilly; Macrogenics; Novartis; OBI; Odonate; Polyphor; Roche; Seattle Genetics; Sermonix |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100 (Meeting Abstract) |
| Autori | Reck M ... Andric Zoran G ... (broj koautora 19) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2022), vol. 17 br. 9, Suppl. S, str. S39-S39 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial (Article) |
| Autori | Peters Solange ... Andric Zoran G ... (broj koautora 26) |
| Info | NATURE MEDICINE, (2022), vol. 28 br. 9, str. 1831-+ |
| Projekat | F. Hoffmann-La Roche, Ltd. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia (Article) |
| Autori | Perovic-Blagojevic Iva M Vekic Jelena Z Macut Djuro P Ignjatovic Svetlana D Miljkovic-Trailovic Milica M Zeljkovic Aleksandra R Spasojevic-Kalimanovska Vesna V Bozic-Antic Ivana B Bjekic-Macut Jelica D Kastratovic-Kotlica Biljana A Andric Zoran G Ilic Dusan S Kotur-Stevuljevic Jelena M |
| Info | BRITISH JOURNAL OF NUTRITION, (2022), vol. 128 br. 4, str. 604-612 |
| Projekat | Serbian Ministry of Science and Education [200110, 451-03-9/2021-14/200161] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies (Article) |
| Autori | Weiss Jared Goldschmidt Jerome Andric Zoran G Dragnev Konstantin H Gwaltney Chad Skaltsa Konstantina Pritchett Yili Antal Joyce M Morris Shannon R Daniel Davey |
| Info | CLINICAL LUNG CANCER, (2021), vol. 22 br. 5, str. 449-460 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC (Article) |
| Autori | Jassem Jacek ... Andric Zoran G ... (broj koautora 19) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 11, str. 1872-1882 |
| Projekat | Roche HoldingGenentech; F. Hoffmann-La Roche Ltd.Hoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Polycystic Ovary Syndrome: A Contemporary Clinical Approach (Review) |
| Autori | Bjekic-Macut Jelica D Vukasin Tamara Velija-Asimi Zelija Burekovic Azra Zdravkovic Marija D Andric Zoran G Brankovic Marija S Crevar-Marinovic Slobodanka Madic Tatjana Stanojlovic Olivera P Milutinovic Danijela V Livadas Sarantis Mastorakos George |
| Info | CURRENT PHARMACEUTICAL DESIGN, (2021), vol. 27 br. 36, str. 3812-3820 |
| Projekat | Ministry of Education, Science and Technological Development, Serbia [451-03-68/2020-14/200007] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2). (Meeting Abstract) |
| Autori | Goel Shom O'Shaughnessy Joyce Tan Antoinette R Milev-Krastev Boris Rugo Hope S Aftimos Philippe Georges Yardley Denise A Andric Zoran G Wolfgang Curt Douglas Sorrentino Jessica Tao Wenli Beelen Andrew Paul Malik Rajesh K Jain Sarika |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. - |
| Projekat | G1 Therapeutics, Inc |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | HERIZON: A phase 1B/2 open-label study of imu-131 HER2/neu peptide vaccine PLUS standard of care chemotherapy with randomization in phase 2 in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction. (Meeting Abstract) |
| Autori | Laeufle Rita ... Andric Zoran G ... Nikolic Ivan V ... Radosavljevic Davorin Z ... (broj koautora 16) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. - |
| Projekat | Imugene Australia |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
